IL-17 inhibitors, however, could be considered for patients who need to be cautious about stroke risk, but caution may be warranted when prescribing IL-17 inhibitors to patients with preexisting pulmonary risk factors such as heavy smoking. The gene discussed is IL17A; the disease is stroke disorder.